GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » 5-Year Yield-on-Cost %

Ascendis Pharma A/S (Ascendis Pharma A/S) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma A/S 5-Year Yield-on-Cost %?

Ascendis Pharma A/S's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Ascendis Pharma A/S's 5-Year Yield-on-Cost % or its related term are showing as below:



ASND's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.955
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Ascendis Pharma A/S's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Ascendis Pharma A/S's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Pharma A/S's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma A/S's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma A/S's 5-Year Yield-on-Cost % falls into.



Ascendis Pharma A/S 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Ascendis Pharma A/S is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Ascendis Pharma A/S  (NAS:ASND) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Ascendis Pharma A/S 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Traded in Other Exchanges
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Ascendis Pharma A/S (Ascendis Pharma A/S) Headlines

From GuruFocus